Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients

Summary

The purpose of this study is to compare the incidence of contrast-induced nephropathy (CIN) following the administration of iopamidol-370 (Iopamiro-370) and iodixanol-320 (Visipaque 320) in patients with moderate-to-severe chronic kidney disease and diabetes mellitus undergoing cardiac angiography.

Timeline

Start

2009-03

Primary completion

2009-09

Completion

2009-09

Drugs

Indications